S. Korean Cloning Pioneer Hospitalized
By The Associated Press,
The Associated Press
| 12. 07. 2005
SEOUL, South Korea -- Prominent South Korean stem cell scientist Hwang Woo-suk, recently embroiled in a scandal over ethics lapses in his research, was hospitalized for extreme stress and fatigue Wednesday, a hospital spokesman said.
Hwang was admitted to Seoul National University Hospital, spokesman Pi Ji-young said. Hwang's doctor said Tuesday that poor health would prevent him from working anytime soon.
It will take about a week of treatment for Hwang to recover from extreme stress and fatigue, said Sung Myung-hoon, another hospital employee.
YTN television briefly broadcast footage of an unshaven Hwang lying on a bed at the hospital.
Last month, Hwang, who gained international renown for creating the world's first human embryos and extracting stem cells from them, publicly apologized for ethical lapses in his research.
After more than a year of denial, Hwang admitted his team at Seoul National University used eggs donated from two junior scientists in his lab. He also acknowledged recently discovering that a hospital doctor paid some women for their eggs used in his research.
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...